Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationProphylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantationPreemptive mechanical ventilation can block progressive acute lung injuryDo platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system.The utility of clinical predictors of acute lung injury: towards prevention and earlier recognitionEarly identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative periodOptimal use of blood in trauma patients.Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period.Plasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational studyThe effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction scoreResuscitation and transfusion principles for traumatic hemorrhagic shock.A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.Transfusion of fresh frozen plasma in non-bleeding ICU patients--TOPIC trial: study protocol for a randomized controlled trial.Correction of subclinical coagulation disorders before percutaneous dilatational tracheotomyTrauma resuscitation requiring massive transfusion: a descriptive analysis of the role of ratio and timeLung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury.Blood product transfusions and clinical outcomes in pediatric patients with acute lung injury.Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests: a single-institution propensity-adjusted cohort study.Tuscan study on the appropriateness of fresh-frozen plasma transfusion (TuSAPlaT).Update on transfusion medicine.Application of the Berlin definition in PROMMTT patients: the impact of resuscitation on the incidence of hypoxemiaRecommendations for the transfusion of plasma and platelets.Reduction in plasma transfusion after enforcement of transfusion guidelines.Optimal use of blood products in severely injured trauma patients.Evaluation and management of shock States: hypovolemic, distributive, and cardiogenic shock.Update and new developments in the management of the exsanguinating patient.Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: Definition, incidence and outcomes.Controversies in the use of fresh frozen plasma in critically ill small animal patients.Risk of Procedural Hemorrhage.Coagulation parameters and major bleeding in critically ill patients with cirrhosis.Red blood cell transfusion is associated with further bleeding and fresh-frozen plasma with mortality in nonvariceal upper gastrointestinal bleeding.Prophylactic Plasma Transfusion Is Not Associated With Decreased Red Blood Cell Requirements in Critically Ill Patients.Protocol guided bleeding management improves cardiac surgery patient outcomes.The effect of fresh frozen plasma in critically ill patients.Reply from authors: the use of blood coagulation products requires a thorough re-evaluation.Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients.Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
P2860
Q24186359-D502B568-5495-48DC-99E0-BDB3FE20AE37Q24186913-C20C090B-338F-4C79-AB31-F0FC2BE22ACEQ24187751-BC533458-22B6-46EB-8541-9B39E7DAD4F6Q24197779-5A260FC3-3314-43FC-94C3-9B004429B899Q26768225-688760E0-C513-4118-8606-021BCA2FAD56Q33376672-A5A81BEA-CC03-4802-AD07-24FDC48A0A4EQ34603444-3A2B49F8-B434-4886-8751-79B0AFAABB33Q34665113-6CB2E2BF-4A65-4CF3-B97D-E6E9D1A105DBQ34988663-04E16353-9971-4E98-B0DD-3B1DD967327BQ35077977-02B27767-A775-48C1-A16B-568A94686A1FQ35106170-0B51471D-9C78-4F18-B36F-3B4265077FD4Q35106675-C6CE97CE-80CD-46BD-ADED-6C9A046B594EQ35161940-F3B9391C-984F-4737-9888-C4FD34BAF2EEQ35174893-B00C3D34-654B-4AB2-8563-5DC42053F661Q35559573-BDEB387D-C55A-411E-A7F3-56985981886CQ35772078-3F315FBC-F8D9-411A-BCD3-D3D8825BEDFBQ35874057-7AFE2BAA-DB51-461E-B7EA-21D410AAAAB2Q35953769-258D7069-C5EC-4B80-8BF6-2A645A0F1CF7Q36220113-0654D9DA-A6F4-40D8-BC96-98F9D21C470FQ36650277-8BE70395-CC83-4C0A-9BF7-9850BBF50B90Q36760558-B81AFF4E-F96D-43B2-95E7-35751DCAF98CQ36874231-066B0AE8-AF0F-4F01-B8DA-1DC7BBD88D22Q36920718-34287FD9-097A-4647-862F-E2F84A374B10Q37096581-DEE361DD-2873-44BD-BDC9-1E3BD017F509Q37209117-0EF9C936-B8E2-4B35-908C-8ED559FA435EQ37800127-36023BB3-32F6-4189-A60D-EE0F10F5E490Q37829253-52C0C89A-08A6-4C37-9205-D73226907AF5Q37867315-A94BB58C-304F-47EB-85C1-E2A1A78A074DQ37900080-84D46708-2735-483B-83C2-5905FD6CA129Q38242952-2518CF52-66A8-403B-826B-A6A189C8FB20Q38325203-8B694224-1D0C-4533-8283-7F80A552D16AQ38719988-F0966BD0-3FCE-4B67-AAD6-B8A677ABC891Q39813610-760007CE-356E-496E-916C-89489F48EC2FQ40158005-D42E8C02-1530-4EF7-B5CB-E02039D2D543Q40342989-53051CE1-C361-46F7-91DF-2FB21C2FBCF9Q41268694-0089E771-4D8D-44B9-BC0F-6337B332058CQ45866452-05B721A7-CF05-48E8-BB0A-5FA415A50D48Q45869083-67CCE983-1711-46B9-91A4-184A0FB96CB2Q47220914-77D638D7-25B5-4CAC-8FF9-40C26A48D3B5Q47905915-F3691D47-0475-4DBB-A6FF-A4F07BFB4016
P2860
Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Fresh frozen plasma and platel ...... ve care unit: benefit or harm?
@ast
Fresh frozen plasma and platel ...... ve care unit: benefit or harm?
@en
type
label
Fresh frozen plasma and platel ...... ve care unit: benefit or harm?
@ast
Fresh frozen plasma and platel ...... ve care unit: benefit or harm?
@en
prefLabel
Fresh frozen plasma and platel ...... ve care unit: benefit or harm?
@ast
Fresh frozen plasma and platel ...... ve care unit: benefit or harm?
@en
P1476
Fresh frozen plasma and platel ...... ve care unit: benefit or harm?
@en
P2093
Walter H Dzik
P304
P356
10.1097/01.CCM.0000214288.88308.26
P407
P433
P50
P577
2006-05-01T00:00:00Z